Skip to content

Medical-device intelligence

NXD: Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna

FDA product code NXD: Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NXD
FDA device name
Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna
Device class
2
Regulation number
866.3332
Medical specialty
Microbiology
Review panel
MI

FDA definition

Novel influenza a virus reagents are used in nucleic acid amplification tests to directly detect and differentiate novel influenza a virus specific rna gene segments in human respiratory specimens or viral cultures. Detection and differentiation of specific rna gene segments aids in the diagnosis of influenza caused by novel influenza a viruses in patients with clinical and epidemiological risk of infection with these viruses. They also aid in the presumptive identification of specific novel influenza a viruses and provide epidemiological information on influenza. These reagents are primers and probes, along with a specific novel influenza virus control.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Sep 30, 2008 to Jul 6, 2010.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
JBAIDS INFLUENZA A/H5 DETECTION KIT, MODEL JRPD-ASY-0136K100287 · NXDU.S. Army Medical Material Development Command510(k)Jul 6, 2010FDA decision date
CDC HUMAN INFLUENZA VIRUS REAL-TIME RT- PCR DETECTION AND CHARACTERIZATION PANELK080570 · NXDCenters for Disease Control and Prevention510(k)Sep 30, 2008FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗